We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure [email protected]
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Pregnant women who contract the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) face an elevated risk of preterm birth, and their newborns are more prone to stillbirth or admission to a neonatal unit. Despite the World Health Organization declaring the end of the coronavirus disease 2019 (COVID-19) pandemic as a global health emergency in May 2023, pregnant women continue to contract SARS-CoV-2. Limited information is available on the impact of SARS-CoV-2 infection in early pregnancy on pregnancy outcomes. Additionally, understanding the safety of vaccination is crucial. Current evidence suggests that SARS-CoV-2 infection in early pregnancy does not seem to heighten the risk of miscarriages. Moreover, vaccinations have demonstrated efficacy in safeguarding both pregnant women and their pregnancies
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.